- Home
- BNR vs CEV Comparison
BNR vs CEV Comparison
Compare BNR & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- CEV
- Stock Information
- Founded
- BNR 2014
- CEV 1999
- Country
- BNR China
- CEV United States
- Employees
- BNR N/A
- CEV N/A
- Industry
- BNR Medical Specialities
- CEV Finance/Investors Services
- Sector
- BNR Health Care
- CEV Finance
- Exchange
- BNR Nasdaq
- CEV Nasdaq
- Market Cap
- BNR 73.5M
- CEV 75.9M
- IPO Year
- BNR 2020
- CEV N/A
- Fundamental
- Price
- BNR N/A
- CEV N/A
- Analyst Decision
- BNR
- CEV
- Analyst Count
- BNR 0
- CEV 0
- Target Price
- BNR N/A
- CEV N/A
- AVG Volume (30 Days)
- BNR 15.0K
- CEV 19.6K
- Earning Date
- BNR 12-31-2024
- CEV 01-01-0001
- Dividend Yield
- BNR N/A
- CEV 4.23%
- EPS Growth
- BNR N/A
- CEV N/A
- EPS
- BNR N/A
- CEV 0.36
- Revenue
- BNR $72,832,704.00
- CEV N/A
- Revenue This Year
- BNR $52.90
- CEV N/A
- Revenue Next Year
- BNR $48.35
- CEV N/A
- P/E Ratio
- BNR N/A
- CEV $29.36
- Revenue Growth
- BNR N/A
- CEV N/A
- 52 Week Low
- BNR $2.62
- CEV $8.83
- 52 Week High
- BNR $9.99
- CEV $10.91
- Technical
- Relative Strength Index (RSI)
- BNR 57.52
- CEV 25.01
- Support Level
- BNR $5.96
- CEV $10.01
- Resistance Level
- BNR $7.14
- CEV $10.75
- Average True Range (ATR)
- BNR 0.50
- CEV 0.08
- MACD
- BNR -0.13
- CEV -0.06
- Stochastic Oscillator
- BNR 35.76
- CEV 6.76
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.